ClinicalTrials.Veeva

Menu

The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Thyroid Cancer, Papillary

Treatments

Procedure: prophylactic central lymph node dissection

Study type

Interventional

Funder types

Other

Identifiers

NCT02418390
H-1404-050-571

Details and patient eligibility

About

The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma.

Full description

The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma. Primary outcome is the surgical completeness, recurrence rate, and successful ablation rate. Secondary outcomes are the incidence of postoperative complications and PTC stage. The enrolled patients were randomly assigned to control group and intervention group (1:1 allocation).

Enrollment

101 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria were as follows:

  1. patients aged 20 to 70 years old
  2. patients diagnosed with PTC or suspicious for PTC on fine needle aspiration or core needle biopsy
  3. patients with no evidence of LNM before and during surgery(cN0)
  4. patients with no evidence of distant metastasis(cM0).

Exclusion criteria were as follows:

  1. patients suspected of advanced PTC(clinically T3 or T4) such as invasion of peripheral organs on preoperative examination
  2. patients who have previous history of cervical radiation therapy or surgery.
  3. pregnant women
  4. uncontrolled diabetes, hypertension, or chronic renal failure
  5. aspirin or anticoagulant medication within 7 days
  6. other clinical trial participation within 30 days
  7. radiation exposure to the head and neck
  8. previous operation to the neck
  9. advanced thyroid cancer including adjacent organ invasion

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

101 participants in 2 patient groups

No prophylactic central dissection
No Intervention group
Description:
Patients underwent total thyroidectomy for papillary thyroid carcinoma, without prophylactic central lymph node dissection
Prophylactic central dissection
Active Comparator group
Description:
Patients underwent total thyroidectomy for papillary thyroid carcinoma, with prophylactic central lymph node dissection
Treatment:
Procedure: prophylactic central lymph node dissection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems